RYTM - Rhythm Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RYTM is currently covered by 12 analysts with an average price target of $120.18. This is a potential upside of $22.72 (23.31%) from yesterday's end of day stock price of $97.46.

Rhythm Pharmaceuticals's activity chart (see below) currently has 150 price targets and 144 ratings on display. The stock rating distribution of RYTM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.16% with an average time for these price targets to be met of 331.76 days.

Highest price target for RYTM is $167, Lowest price target is $94, average price target is $127.83.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 22-Dec-2025. First documented stock forecast 30-Oct-2017.

Currently out of the existing stock ratings of RYTM, 42 are a BUY (100%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 18-Sep-2024

$123

$17.99 (17.13%)

$110

17 days ago
(22-Dec-2025)

12/13 (92.31%)

$10.86 (9.68%)

112

Buy

Since 21-Oct-2024

$140

$34.99 (33.32%)

$120

22 days ago
(17-Dec-2025)

1/3 (33.33%)

$28.14 (25.16%)

261

Buy

Since 08-Aug-2022

$157

$51.99 (49.51%)

$139

27 days ago
(12-Dec-2025)

9/12 (75%)

$39.38 (33.48%)

186

Buy

Since 17-Sep-2024

$167

$61.99 (59.03%)

$142

27 days ago
(12-Dec-2025)

3/6 (50%)

$49.38 (41.98%)

88

Buy

Since 02-Mar-2023

$141

$35.99 (34.27%)

$114

27 days ago
(12-Dec-2025)

10/11 (90.91%)

$23.38 (19.88%)

302

Show more analysts

Please expand the browser size to see the chart

What is RYTM (Rhythm Pharmaceuticals) average time for price targets to be met?

On average it took 331.76 days on average for the stock forecasts to be realized with a an average price target met ratio 85.16

Which analyst has the current highest performing score on RYTM (Rhythm Pharmaceuticals) with a proven track record?

PAUL MATTEIS

Which analyst has the most public recommendations on RYTM (Rhythm Pharmaceuticals)?

Paul Matteis works at STIFEL and has 17 price targets and 14 ratings on RYTM

Which analyst is the currently most bullish on RYTM (Rhythm Pharmaceuticals)?

Jonathan Wolleben with highest potential upside - $61.99

Which analyst is the currently most reserved on RYTM (Rhythm Pharmaceuticals)?

Graig Suvannavejh with lowest potential downside - -$99.01

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?